New drug combo aims to cut stroke disability in half
NCT ID NCT07252544
First seen Jan 04, 2026 · Last updated May 17, 2026 · Updated 20 times
Summary
This study tests whether two drugs, isosorbide mononitrate and butylphthalide, can lower the risk of disability after a lacunar stroke—a type of small stroke deep in the brain. About 3,156 adults who had a stroke within the past week will take one or both drugs or a placebo for up to a year. The goal is to see if these treatments help people recover better and avoid long-term problems like trouble thinking, another stroke, or death.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CEREBRAL SMALL VESSEL DISEASES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.